A Phase 1b/2 Study of FT 2102 in Patients with Advanced Solid Tumors and Gliomas with an IDH1 Mutation

February 11, 2019
https://clinicaltrials.gov/ct2/show/NCT03684811
Cancer - Brain
Principal Investigator: Tobias Walbert, MD

 Solid Tumors, Gliomas, IDH1 Mutation

Accepting Participants